Cite
IL-12 immunotherapy of minimal residual disease in murine models of HPV16-associated tumours: induction of immune responses, cytokine production and kinetics of immune cell subsets.
MLA
Indrová, Marie, et al. “IL-12 Immunotherapy of Minimal Residual Disease in Murine Models of HPV16-Associated Tumours: Induction of Immune Responses, Cytokine Production and Kinetics of Immune Cell Subsets.” International Journal of Oncology, vol. 32, no. 2, Feb. 2008, pp. 499–507. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=18202774&authtype=sso&custid=ns315887.
APA
Indrová, M., Bieblová, J., Bubeník, J., & Reinis, M. (2008). IL-12 immunotherapy of minimal residual disease in murine models of HPV16-associated tumours: induction of immune responses, cytokine production and kinetics of immune cell subsets. International Journal of Oncology, 32(2), 499–507.
Chicago
Indrová, Marie, Jana Bieblová, Jan Bubeník, and Milan Reinis. 2008. “IL-12 Immunotherapy of Minimal Residual Disease in Murine Models of HPV16-Associated Tumours: Induction of Immune Responses, Cytokine Production and Kinetics of Immune Cell Subsets.” International Journal of Oncology 32 (2): 499–507. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=18202774&authtype=sso&custid=ns315887.